BBOT BridgeBio Oncology Therapeutics, Inc.
Nasdaq · SEC CIK 1869105 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 41 since 2024-02-13, latest 2026-09-14 16:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Elmelech Idan | COO, Principal Financial Ofcr | — | — |
| Beltran Pedro | Pres, CEO, Dir | — | — |
| Ben Yong | Chief Med, Dev Off | — | — |
| Mehra Uneek | Former Off | — | — |
| Cobo Marc | Principal Accounting Off | — | — |
| BridgeBio Pharma, Inc. | 10% | — | — |
| Chen Bihua | Dir, 10% | — | — |
Transactions 23
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-14 16:24 | 2026-09-10 | BBOT | Cobo Marc | Principal Accounting Off | A - Grant | $0.00 | +9,038 | 14.3K | +170% | $0 |
| D | 2026-09-14 16:24 | 2026-09-10 | BBOT | Cobo Marc | Principal Accounting Off | F - Tax | $5.52 | -203 | 14.1K | -1% | -$1,121 |
| 2026-07-06 18:00 | 2026-07-01 | BBOT | Cobo Marc | Principal Accounting Off | F - Tax | $7.80 | -125 | 5,306 | -2% | -$975 | |
| 2026-07-06 18:00 | 2026-07-01 | BBOT | Elmelech Idan | COO, Principal Financial Ofcr | F - Tax | $7.80 | -343 | 14.5K | -2% | -$2,675 | |
| 2026-07-06 18:00 | 2026-07-01 | BBOT | Ben Yong | Chief Med, Dev Off | F - Tax | $7.80 | -1,047 | 44.6K | -2% | -$8,167 | |
| 2026-07-06 18:00 | 2026-07-01 | BBOT | Beltran Pedro | Pres, CEO, Dir | F - Tax | $7.80 | -1,047 | 44.6K | -2% | -$8,167 | |
| MI | 2026-07-06 16:34 | 2026-07-01 | BBOT | Chen Bihua | Dir, 10% | J - Other | $0.00 | 0 | 6.08M | New | $0 |
| 2026-05-05 19:05 | 2026-04-01 | BBOT | Ben Yong | Chief Med, Dev Off | F - Tax | $9.03 | -1,047 | 45.6K | -2% | -$9,454 | |
| 2026-05-05 19:03 | 2026-04-01 | BBOT | Beltran Pedro | Pres, CEO, Dir | F - Tax | $9.03 | -1,047 | 45.6K | -2% | -$9,454 | |
| 2026-05-05 19:01 | 2026-04-01 | BBOT | Mehra Uneek | Former Off | F - Tax | $9.03 | -524 | 22.8K | -2% | -$4,732 | |
| D | 2026-03-12 | 2026-03-10 | BBOT | Beltran Pedro | CSO | A - Grant | $0.00 | +46.7K | 46.7K | New | $0 |
| D | 2026-03-12 | 2026-03-10 | BBOT | Mehra Uneek | CFO | A - Grant | $0.00 | +23.3K | 23.3K | New | $0 |
| D | 2026-03-12 | 2026-03-10 | BBOT | Ben Yong | Chief Med, Dev Off | A - Grant | $0.00 | +46.7K | 46.7K | New | $0 |
| 2025-10-16 | 2025-10-10 | BBOT | BridgeBio Pharma, Inc. | 10% | J - Other | — | +784.7K | 14.59M | +6% | — | |
| DI | 2025-08-13 | 2025-08-11 | BBOT | Chen Bihua | Dir, 10% | D - Sale to Iss | $0.00 | -152.9K | 4.53M | -3% | $0 |
| DI | 2025-08-13 | 2025-08-11 | BBOT | Chen Bihua | Dir, 10% | M - OptEx | — | +4.17M | 4.68M | +820% | — |
| DMI | 2025-08-13 | 2025-08-11 | BBOT | Chen Bihua | Dir, 10% | A - Grant | $10.72 | +10.95M | 1.54M | New | +$117.39M |
| D | 2025-08-11 | 2025-08-11 | BBOT | Schmid John P. | Former Dir | M - OptEx | — | +30.0K | 30.0K | New | — |
| D | 2025-08-11 | 2025-08-11 | BBOT | Holman Albert A III | Former Dir | M - OptEx | — | +30.0K | 30.0K | New | — |
| D | 2025-08-11 | 2025-08-11 | BBOT | McKenna Mark C. | Former Dir | M - OptEx | — | +30.0K | 30.0K | New | — |
| I | 2024-02-13 | 2024-02-13 | BBOT | Helix Holdings II LLC | Dir, 10% | A - Grant | $10.00 | +509.0K | 509.0K | New | +$5.09M |
| I | 2024-02-13 | 2024-02-13 | BBOT | Chen Bihua | CEO, COB, Dir, 10% | A - Grant | $10.00 | +509.0K | 509.0K | New | +$5.09M |
| MI | 2024-02-13 | 2024-02-13 | BBOT | Chen Bihua | CEO, COB, Dir, 10% | P - Purchase | $10.00 | +2.40M | 903.6K | New | +$24.00M |
Purchase Sale Sale after option exercise All abbreviations